Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening
Status:
Withdrawn
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate Suprep bowel preparation, with and without the
anti-gas medication simethicone, in terms of efficacy and patient tolerability in the
preparation of patients undergoing routine colonoscopy for colorectal cancer screening.
Phase:
N/A
Details
Lead Sponsor:
Mercy Medical Center, Des Moines, Iowa MercyOne Des Moines Medical Center